Skip to main content
Quality of Recovery ScoresDrugPhase 4

What this study is

Patients undergoing cardiac surgery often experience moderate to severe pain in the early postoperative period. A number of methods have been used to help control pain after surgery; however, each of these techniques adds additional costs and risks. A simple and effective way to decrease this pain is to administer a long-acting opioid in the operating room. Methadone is a opioid that can produce analgesia (pain relief) that lasts up to 48 hours when given in large doses (0.3 to 0.4 mg/kg). Previous studies have demonstrated that both pain and requirements for analgesic medications are significantly reduced for up to three days after surgery if methadone is given at induction (the start) of anesthesia. In the study that was performed at Evanston Hospital, cardiac surgical patients who were given methadone also appeared to "feel better" after surgery compared to those given a standard or typical intraoperative opioid. The aim of this randomized clinical trial is to determine whether overall quality of postoperative recovery can be enhanced if methadone is given in the operating room. Quality of recovery will be determined by using a validated scoring system, the QoR 40, which will be given to patients to complete on the first three days after surgery.

What's being tested

  • Methadone

    Intervention · DRUG

    Methadone will be provided at induction of anesthesia

  • Saline

    Intervention · DRUG

    Saline will be administered at induction of anesthesia

Study details

Sponsor
Endeavor Health
Conditions
Quality of Recovery Scores
Enrolling
130 people
Starts
2018-12-25
Est. completion
2021-07-25
Design
Quadruple-blind, randomized, parallel groups, Phase 4
Record
View on ClinicalTrials.gov ↗